Platform Supporting the Discovery of Agents against HSV

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are globally prevalent human pathogens associated with a wide range of diseases, from mild conditions such as herpes labialis (cold sores) to serious infections such as encephalitis and meningitis. HSV can establish a lifelong latent infection in neurons of the peripheral nervous system and can reactivate under certain circumstances. Despite ongoing research, the mechanisms underlying HSV latency are not fully understood.

To expedite the discovery of prophylactic and therapeutic agents targeting HSV reactivation, WuXi Biology has established a comprehensive platform encompassing both in vitro and in vivo HSV assays. At the 2025 International Conference on Antiviral Research (ICAR), our experts presented a poster showcasing the platform’s broad range of cell-based and animal HSV models available to researchers.

Poster_HSV Assay Platform_ICAR 2025

Download